|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 66.4 TWD | -4.32% |
|
+12.93% | +14.29% |
| Mar. 19 | BIONET Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | BIONET Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
BIONET Corp. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 980.38 million compared to TWD 921.42 million a year ago.
Net income was TWD 37.97 million compared to TWD 26.62 million a year ago. Basic earnings per share from continuing operations was TWD 0.8 compared to TWD 0.56 a year ago. Diluted earnings per share from continuing operations was TWD 0.8 compared to TWD 0.56 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +14.29% | 96.27M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
BIONET CORP. 
